- Home
- APLM vs NITO Comparison
APLM vs NITO Comparison
Compare APLM & NITO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- NITO
- Stock Information
- Founded
- APLM 2016
- NITO 2009
- Country
- APLM United States
- NITO Israel
- Employees
- APLM N/A
- NITO N/A
- Industry
- APLM Blank Checks
- NITO
- Sector
- APLM Finance
- NITO
- Exchange
- APLM Nasdaq
- NITO NYSE
- Market Cap
- APLM 6.9M
- NITO 6.6M
- IPO Year
- APLM N/A
- NITO N/A
- Fundamental
- Price
- APLM $6.49
- NITO $0.25
- Analyst Decision
- APLM
- NITO
- Analyst Count
- APLM 0
- NITO 0
- Target Price
- APLM N/A
- NITO N/A
- AVG Volume (30 Days)
- APLM 7.8K
- NITO 1.2M
- Earning Date
- APLM 08-13-2025
- NITO 08-13-2025
- Dividend Yield
- APLM N/A
- NITO N/A
- EPS Growth
- APLM N/A
- NITO N/A
- EPS
- APLM N/A
- NITO N/A
- Revenue
- APLM $198,000.00
- NITO $232,000.00
- Revenue This Year
- APLM $415.15
- NITO N/A
- Revenue Next Year
- APLM N/A
- NITO N/A
- P/E Ratio
- APLM N/A
- NITO N/A
- Revenue Growth
- APLM N/A
- NITO 24.74
- 52 Week Low
- APLM $4.47
- NITO $0.16
- 52 Week High
- APLM $35.98
- NITO $3.49
- Technical
- Relative Strength Index (RSI)
- APLM 47.85
- NITO 45.09
- Support Level
- APLM $6.21
- NITO $0.22
- Resistance Level
- APLM $6.80
- NITO $0.26
- Average True Range (ATR)
- APLM 0.52
- NITO 0.02
- MACD
- APLM 0.00
- NITO 0.00
- Stochastic Oscillator
- APLM 51.61
- NITO 52.94
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About NITO N2OFF INC
N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork. The Company has two reportable segments: Pathogen prevention and prolong shelf life, and the N2O emissions Global warming solutions.